¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pulmonary ventilatory capacity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • expiratory vital capacity
    ³¯¼ûÆóȰ·®, È£±âÆóȰ·®
  • effective capacity
    À¯È¿¿ëÀû
  • forced vital capacity
    °­Á¦ÆóȰ·®
  • functional capacity
    ±â´É¿ë·®
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • heat capacity
    ¿­¿ë·®
  • iron-binding capacity
    ö°áÇÕ´É
  • inspiratory capacity
    µé¼û¿ëÀû, Èí±â¿ëÀû
  • inspiratory vital capacity
    µé¼ûÆóȰ·®, Èí±âÆóȰ·®
  • maximal aerobic capacity
    ÃÖ´ë»ê¼Ò¿ë·®
  • maximal breathing capacity
    ÃÖ´ëÈ£Èí¿ë·®
  • maximal tubular excretory capacity
    ÃÖ´ë¿ä¼¼°ü¹è¼³·®
  • maximal tubular reabsorption capacity
    ÃÖ´ë¿ä¼¼°üÀçÈí¼ö·®
  • maximum breathing capacity
    ÃÖ´ëÈ£Èí¿ë·®
  • physical working capacity
    ½ÅüÀûÀÛ¾÷´É·Â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary edema
    ÆóºÎÁ¾, ÇãÆÄºÎÁ¾
  • idiopathic pulmonary fibrosis
    Ư¹ß¼ºÆó¼¶À¯Áõ
  • pulmonary arteriovenous fistula
    Æóµ¿Á¤¸Æ»û±æ, ÇãÆÄµ¿Á¤¸Æ»û±æ
  • pulmonary hamartoma
    Æó°ú¿ÀÁ¾, ÇãÆÄ°ú¿ÀÁ¾
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • pulmonary insufficiency
    Æó±â´ÉºÎÁ·, ÇãÆÄ±â´ÉºÎÁ·
  • pulmonary
    Æó-, ÇãÆÄ-
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð, ÇãÆÄµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð, ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð
  • total pulmonary resistance
    ÆóÇ÷°üÀúÇ×, ÇãÆÄÇ÷°üÀúÇ×
  • pulmonary sequestration
    ÆóºÐ¸®Áõ, ÇãÆÄºÐ¸®Áõ
  • pulmonary surfactant
    ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄ°è¸éȰ¼ºÃ¼
  • pulmonary perfusion scan
    Æó°ü·ù½ºÄµ, ÇãÆÄ°ü·ù½ºÄµ
  • pulmonary trunk
    Æóµ¿¸Æ, ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective capacity
    À¯È¿¿ë·®
  • egg laying capacity
    »ê¶õ´É·Â
  • electric capacity
    Àü±â¿ë·®
  • expiratory vital capacity
    ³»½°ÆóȰ·®
  • forced vital capacity
    °­Á¦ÆóȰ·®
  • functional capacity
    ±â´É¿ë·®
  • functional residual capacity
    ±â´ÉÀûÀܱâ¿ë·®
  • heat capacity
    ¿­¿ë·®
  • inspiratory capacity
    µé¼û¿ëÀû
  • inspiratory vital capacity
    µé¼ûÆóȰ·®
  • iron-binding capacity
    ö°áÇÕ´É
  • legal capacity
    ¹ýÀû´É·Â
  • maximal aerobic capacity
    ÃÖ´ë»ê¼Ò¿ë·®
  • maximal breathing capacity
    ÃÖ´ëÈ£Èí¿ë·®
  • maximal tubular excretory capacity
    ÃÖ´ë¿ä¼¼°ü¹è¼³·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • heat capacity
    ¿­¿ë·®(æðé»åÖ).
  • inspiratory capacity
    Èí½Ä¿ë·®, Èí±â¿ëÀû.
  • inspiratory capacity
    Èí½Ä¿ë·®(ýåãÓé»Õá), Èí±â¿ëÀû(ýåѨé»îÝ) .
  • inspiratory capacity
    Èí½Ä¿ë·®,Èí±â¿ëÀû
  • inspiratory vital capacity
    Èí±âÆóȰ·®(ýåѨøËüÀÕá).
  • inspiratory vital capacity
    Èí±âÆóȰ·®.
  • predicted vital capacity
    ¿¹ÃøÆóȰ·®(çãö´øËüÀåÖ).
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Hamman Rich syndrome =diffuse interstitial pulmonary fibrosis
    ÇØ¸Õ- ¸®Ä¡ÁõÈıº.
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • acute pulmonary edema
    ±Þ¼º ÆóºÎÁ¾(ÐáàõøËÝ©ðþ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adsorption capacity
    ÈíÂø´É(ýåó·Òö).
  • agglutinating capacity
    ÀÀÁý´É
  • antigen binding capacity
    Ç׿ø°áÇÕ´É(¡­Ì¿ùêÒö).
  • atrial capacity
    ½É¹æ¿ëÀû(ãýÛ®é»îÝ)
  • bladder capacity
    ¹æ±¤¿ëÀû
  • breathing capacity
    È£Èí¿ë·®(¡­é»åÖ)
  • buffering capacity
    ¿ÏÃæ´É(èÐõúÒö)
  • capacity
    ¿ëÀû, ·®, ´É·Â, ´É
  • cranial capacity
    µÎ°³³»¿ë·®(¡­Ò®é»åÖ).
  • diffusing capacity
    È®»ê´É
  • diffusing capacity
    È®»ê´É, È®»ê¼º ´É·Â(¡­Òöæ³).
  • diffusion capacity
    È®»ê´É(üªß¤Òö)
  • effective capacity
    À¯È¿¿ë·®.
  • electric capacity
    Àü±â¿ë·®(ï³Ñ¨é»Õá)
  • expiratory vital capacity =EVC
    È£½ÄÆóȰ·®(¡­øËüÀåÖ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Pulmonary artery
    ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
  • Pulmonary trunk
    ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] Æóµ¿¸Æ
  • Bifurcation of pulmonary trunk
    ÇãÆÄµ¿¸Æ°¥¸²
    [¿¾ ¿ë¾î] Æäµ¿¸ÆÀ̺Ð
  • Orifice of pulmonary trunk
    ÇãÆÄµ¿¸Æ±¸¸Û
    [¿¾ ¿ë¾î] Æóµ¿¸Æ±¸
  • Sinus of pulmonary trunk
    ÇãÆÄµ¿¸Æµ¿±¼
    [¿¾ ¿ë¾î] Æóµ¿¸Æµ¿
  • Pulmonary glomus
    ÇãÆÄµ¿¸ÆÅ丮
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÃ¼
  • Pulmonary valve
    ÇãÆÄµ¿¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
  • Valve of pulmonary trunk
    ÇãÆÄµ¿¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
  • Pulmonary surface
    ÇãÆÄ¸é
    [¿¾ ¿ë¾î] Æó¸é
  • Pulmonary hilum
    ÇãÆÄ¹®
    [¿¾ ¿ë¾î] Æó¹®
  • Pulmonary root
    ÇãÆÄ»Ñ¸®
    [¿¾ ¿ë¾î] Æó±Ù
  • Pulmonary juxtaesophageal lymph nodes
    ÇãÆÄ½Äµµ¿·¸²ÇÁÀý
    [¿¾ ¿ë¾î] Æó½Äµµ¹æÀÓÆÄÀý
  • Pulmonary plexus
    ÇãÆÄ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Æó½Å°æÃÑ
  • Pulmonary bud
    ÇãÆÄ½Ï
    [¿¾ ¿ë¾î] Æó·Ú
  • Pulmonary ligament
    ÇãÆÄÀδë
    [¿¾ ¿ë¾î] Æó°£¸·
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â(Áõ)
  • pulmonary capillary
    Æó¸ð¼¼°ü
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulmonary circulation
    Æó¼øÈ¯
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • pulmonary congestion
    Æó¿ïÇ÷
  • pulmonary edema
    ÆóºÎÁ¾
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ
  • pulmonary emphysema
    Æó±âÁ¾
  • pulmonary eosinophilia
    ÆóÈ£»ê±¸Áõ°¡Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • pulmonary function test
    Æó±â´É°Ë»ç
  • pulmonary hemorrhage
    ÆóÃâÇ÷
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º°ñº´Áõ
  • pulmonary infarction
    Æó°æ»öÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SAVE saved-young-life equivalent; sudden A-ventilatory event; survival and ventricular enlargement [trial...
VE vaginal examination; Venezuelan encephalitis; venous emptying; venous extension; ventilation; ventil...
VMT vasomotor tonus; ventilatory muscle training; ventromedial tegmentum
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VE/VO2 Ventilatory equivalent for oxygen
V(E)/VCO2 ventilatory equivalent for CO2
CC Closing capacity
CCSE Cognitive Capacity Screening Examination
DLCO Diffusing capacity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophilic pulmonary syndrome
    È£»ê¼º Æó ÁõÈıº
    ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÆóÆ÷ ¼¼Ã´À̳ª »ý°Ë»ó È£»ê±¸°¡ Æó Á¶Á÷ÀÇ ¸»Ãʺο¡ Ä§ÂøµÈ ¼Ò°ßÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ» ÀǹÌÇÑ´Ù. Ç÷¾× È£»ê±¸ Áõ°¡°¡ ´ëºÎºÐ °üÂûµÈ´Ù. ¸¸¼º È£»ê±¸¼º Æó·ÅÀº ÁÖ·Î ¿©ÀÚ¿¡ ³ªÅ¸³ª¸ç, ¹ß¿­, ¹ßÇÑ, üÁß °¨¼Ò, È£Èí °ï¶õÀÌ Æ¯Â¡ÀÌ´Ù. Ä¡·á´Â °æ±¸
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº Æó °ñ°üÀýº´Áõ
  • left inferior pulmonary vein
    ¾Æ·¡ ¿Þ ÇãÆÄ Á¤¸Æ
  • main pulmonary artery
    ÁÖ Æó µ¿¸Æ
  • mediastino pulmonary
    Á¾°Ý Æó
  • mild pulmonary valve stenosis
    °æµµÀÇ Æó µ¿¸ÆÆÇ ÇùÂøÁõ
  • multiple pulmonary emboli
    ´Ù¹ß¼º Æó »öÀü
  • obstructive pulmonary emphysema
    Æó¼â¼º Æó ±âÁ¾
  • orifices of pulmonary vein
    ÇãÆÄ Á¤¸Æ ±¸¸Û
  • pulmonary abscess
    Æó ³ó¾ç
    Æó ³»ÀÇ ³ó Çü¼º.
  • pulmonary actinomycosis
    Æó ¹æ¼±±ÕÁõ
  • pulmonary alveolar proteinosis
    ÆóÆ÷ ´Ü¹éÁõ
    ÆóÆ÷ ³»¿¡ Æó °è¸éü ¼ººÐ°ú ºñ½ÁÇÑ ÀÎ ÁöÁúÀÌ ÃàÀûµÇ´Â ÁúȯÀÌ´Ù. ÀÌ ÁúȯÀº ÀÏÂ÷Àû
  • pulmonary alveoli
    ÆóÆ÷
  • pulmonary angiography
    Æó Ç÷°ü Á¶¿µ, Æó Ç÷°ü Á¶¿µ¼ú
  • pulmonary arterial hypertension
    Æó ¼øÈ¯ ½Â¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
heat capacity <chemistry> The amount of energy required to raise the temperature of an object by one degree Celsius (or Kelvin), it is represented by the symbol C and is given in units of J/K.
(09 Jan 1998)
hospital bed capacity The number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.
(12 Dec 1998)
specific heat capacity <chemistry> The amount of energy required to raise the temperature of one gram of a substance by one degree Celsius (or Kelvin).
(09 Jan 1998)
diffusing capacity The amount of oxygen taken up by pulmonary capillary blood per minute per unit average oxygen pressure gradient between alveolar gas and pulmonary capillary blood; units are: ml/min/mm Hg; also applied to other gases such as carbon monoxide.
(05 Mar 2000)
inspiratory capacity The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the tidal volume and the inspiratory reserve volume. Common abbreviation is ic.
(12 Dec 1998)
iron-binding capacity The capacity of iron-binding protein in serum (transferrin) to bind serum iron.
(05 Mar 2000)
oxygen capacity The maximum quantity of oxygen that will combine chemically with the haemoglobin in a unit volume of blood; normally it amounts to 1.34 ml of O2 per gm of Hb or 20 ml of O2 per 100 ml of blood.
(05 Mar 2000)
thermal capacity <chemistry> The amount of energy required to raise the temperature of an object by one degree Celsius (or Kelvin), it is represented by the symbol C and is given in units of J/K.
(09 Jan 1998)
total iron binding capacity <biochemistry, haematology> A test that measures indirectly the transferrin level in the bloodstream.
Transferrin is a protein that carries iron in the body. Normal values are 240 to 450 mcg/dl. This test is used to evaluate anaemia. Greater than normal total iron binding capacity can be seen in: iron deficiency anaemia, late pregnancy and polycythaemia vera.
Lower than normal total iron binding capacity can be seen in cirrhosis, sickle cell anaemia, hypoproteinaemia, pernicious anaemia and haemolytic anaemia. The use of birth control pills can lead to increased total iron binding capacity measurements.
Acronym: TIBC
(12 Jan 1998)
total lung capacity The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: vital capacity plus residual volume; inspiratory capacity plus functional residual capacity; tidal volume plus inspiratory reserve volume plus functional residual capacity; tidal volume plus inspiratory reserve volume plus expiratory reserve volume plus residual volume.
(12 Dec 1998)
forced vital capacity Vital capacity measured with the subject exhaling as rapidly as possible; data relating volume, expiratory flow, and time form the basis for other pulmonary function tests, e.g., flow-volume curve, forced expiratory volume, forced expiratory time, forced expiratory flow.
(05 Mar 2000)
functional residual capacity The volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is frc.
(12 Dec 1998)
acute pulmonary alveolitis Acute inflammation involving exudate into the pulmonary alveoli and impaired gas exchange; may result in necrosis with haemorrhage into the lungs; occurs in Goodpasture's syndrome, in association with a glomerulonephritis.
(05 Mar 2000)
acute pulmonary eosinophilia <chest medicine> A self-limiting inflammation in the lungs where there is associated infiltration of eosinophils into lung tissue. Chest X-ray reveals pulmonary infiltrates and full blood count shows increased numbers of eosinophils.
The cause is unknown and the disease often resolves without treatment. Some forms may be treated with oral corticosteroids. Complications include restrictive cardiomyopathy due to fibrosis of the lining of the heart.
(27 Sep 1997)
adenomatosis, pulmonary A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterised by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á